Skip to Main Content

Try STAT+ TODAY

Boston

Most Read

Biotech Angus Chen

A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies

Health Megan Molteni

Sex of the fetus influences the mother’s response to Covid-19 infection, new research shows

Health Gideon Gil

‘I can still feel it’: Groundbreaking arm amputation surgery makes a ‘phantom’ hand seem real

Health Elizabeth Cooney

Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder

Biotech Damian Garde

The novel coronavirus attacks the lungs. A biotech company sees a common enzyme as key to protecting them

Biotech Helen Branswell

Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine

In the Lab Sharon Begley

Using human brain tissue in lab dishes, researchers show herpes link to Alzheimer’s

Biotech Kate Sheridan

The coronavirus sneaks into cells through a key receptor. Could targeting it lead to a treatment?

All Coverage

Biotech Ryan Cross — The Boston Globe

Can Biogen’s backup plan for Alzheimer’s succeed?

In the Lab Akila Muthukumar

Lattes and gummies: Food science inspires a new approach to treating gut and liver injury

advertisement

Health Tech Tino Delamerced

He had an M.D. and a Ph.D. but didn’t match into a residency. It was the push he needed to jump into health tech

In the Lab Rebecca Ostriker and Deirdre Fernandes — The Boston Globe

Real estate developer reneges on multimillion-dollar pledge to Harvard-led Covid project

Health Tech Pranshu Verma — Boston Globe

Private equity firms to acquire Athenahealth for $17 billion

Biotech Jon Chesto — Boston Globe

As scientific labs replace offices, pushback is mounting from wary neighbors

Jeremy C. Fox — Boston Globe

MIT professor sues after he was forced to resign from institute following sexual harassment allegations

Health Tech Isabella Cueto

A new surgical robot is smaller, nimbler, and cheaper, its maker claims. But will it be better for patients?

Biotech Kate Sheridan

Graduate students launch an entrepreneurship program to bring new faces to biotech

Biotech Damian Garde and Adam Feuerstein

Biogen admits Aduhelm launch ‘slower than we anticipated’

Biotech Jon Chesto — Boston Globe

Boston Scientific completes $1 billion acquisition of Israeli firm

The Pharmalot View Ed Silverman

‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues

Biotech Anissa Gardizy — Boston Globe

Adagio raises $300 million in IPO, looks to advance Covid-19 antibody therapy

Biotech Kate Sheridan

Amylyx is breaking all of biotech’s unwritten rules — and still raising impressive sums

Health Kevin Lin

How a 3D-printed graft could speed healing of ruptured eardrums

Health Eric Boodman

With fewer than 400 progeria patients worldwide, testing a CRISPR cure will be challenging

Exclusive Erin Brodwin

In a new role at health tech startup Maven, Neel Shah wants to make sure pregnant people aren’t ‘lost’

Health Kevin Lin

How a new buddy system is helping health workers grapple with Covid’s toll

Biotech Felice J. Freyer — Boston Globe

What’s next for the new Alzheimer’s drug? Lots of thorny issues ahead

Biotech Adam Feuerstein

German drug maker MorphoSys to buy Constellation Pharma in $1.7 billion deal

Health Andrew Joseph

Aiming to diversify science journalism, STAT creates fellowship named for reporter Sharon Begley

Health Rebecca Ostriker and Andrea Estes — The Boston Globe

The inside story of a Covid-19 outbreak that killed 76 veterans at a Massachusetts senior-care center

Biotech Jonathan Saltzman — Boston Globe

Atlas Venture launches another biotech to tackle vision loss

Health Tech Mario Aguilar

Inside Pear’s ambitious plan to become the most dominant player in digital therapeutics

Biotech Jonathan Saltzman — Boston Globe

Moderna’s CEO says he ‘didn’t lose a minute of sleep’ over potential waiver of vaccine patents